Impact of HER2-Low Status in Patients With Early-Stage Breast Cancer and Non–Pathological Complete Response After Neoadjuvant Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of HER2-low status for patients with early-stage breast cancer and non-pCR after neoadjuvant chemotherapy: a National Cancer Database Analysis
Breast Cancer Res Treat 2023 Dec 08;[EPub Ahead of Print], H Li, JK Plichta, K Li, Y Jin, SM Thomas, F Ma, L Tang, Q Wei, YW He, Q Chen, Y Guo, Y Liu, J Zhang, S LuoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.